glp-1 drugs and addiction Medications Get at the Heart of Addiction: Study The Rise of GLP-1 Medications:

Adapted from French by DeepL/sb This news story has been written and carefully fact-checked by an external editorial team

Pharmacovigilance studies indicate that GLP-1RAs, with the exception of albiglutide, demonstrate potential associations with pancreatic cancer risk, particularly evident in exenatide-treated patients who exhibit elevated cancer incidence rates

Figure 1 6.6 Therapeutic and translational opportunities targeting mitochondrial dysfunction in infection Targeting mitochondrial dysfunction offers a promising strategy for HDTs

CD8+ T cells produce perforin and granzyme to provide protection against viral infection, resulting in a decline in the viral load

Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor

Franczyk A, Stolarz-Skrzypek K, Wesoowska A, Czarnecka D